Dermapen | Face [Skin Needling]
TREATMENTS:
Face Only $400 [5 Tre atments/$350 each] $1750
Face, Neck & Decolletage $450 [5 Treatments] $1995
Dermapen™ is a revolutionary micro-needling device which aims to tighten, lift and rejuvenate skin with minimal downtime. The Dermapen benefits:
Safer and more effective in piercing the skin than traditional skin needling rollers
Has a superior effect on collagen and elastin rejuvenation
Multi-speed and adjustable needle depth
Highest effectiveness
Effectively treat hard-to-reach places
Promotes scar-less healing and natural collagen reproduction
Improves the appearance of ageing, wrinkles, uneven skin tone, uneven texture, stretch marks and scar tissue on face and body areas.
Dermapen treatments are fast, effective, comfortable and offer results after just one treatment.
Based on your concerns your we may recommend a series of treatments for optimal results.
Dermapen’s oscillating action effortlessly glides over the skin and stimulates the body’s own natural healing and regenerative process.
Contraindications:
Dermapen treatments are not suitable for patients experiencing:
Papulopustular rosacea, Acne vulgaris stage III-IV, Herpes simplex, Warts, Scleroderma, Bacterial / fungal infections, Open lesions, Solar Keratosis, Skin Cancer, Haemophilia, Pregnancy
Precautions:
If you are prone to herpes simplex (cold sores), it is recommended to take or apply a targeted prophylasis, such as acyclovir, to prevent a possible outbreak.
For tanned to dark complexions or skins prone to post-inflammatory hyperpigmentation, it is recommended to use a melanin inhibiting skin regime for a least 2 weeks prior to a Dermapen clinical treatment.
Dermapen™ is a revolutionary micro-needling device which aims to tighten, lift and rejuvenate skin with minimal downtime.
Face Only $400 [5 Treatments/$350 each] $1750
Face, Neck & Decolletage $450 [5 Treatments] $1995
Hands [with Face Treatment $50
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.